Abstract: A process includes receiving credentials associated with a request to access a computer platform. The credentials include a password and a user identification. The process includes determining a key handle and a reference cryptographic digest corresponding to the user identification. The process includes determining a second cryptographic digest corresponding to the user identification. Determining the second cryptographic digest includes providing the key handle and the password to a security processor of the computer platform and initiating an operation by the security processor to apply a keyed-hashing function to the password based on a cryptographic key corresponding to the key handle to provide the second cryptographic digest. The security processor stores the cryptographic key. The process includes regulating access to the computer platform based on a comparison of the second cryptographic digest to the reference cryptographic digest.

Abstract: The present invention generally relates to a pharmaceutical composition of suitable HIF prolyl hydroxylase inhibitors. Preferably, the present invention discloses novel formulations of the compound of formula (Ia), or pharmaceutically acceptable salts of compounds of formula (Ia). More particularly the present invention relates to the pharmaceutical composition of compounds of formula (Ia) comprising compounds of formula (Ia) or its pharmaceutically acceptable salts.